Extracorporeal photopheresis treatment for steroid resistant graft versus host disease in pediatrics: single center experience
AuthorAksoy, Basak Adakli
Savci, Yunus Emre
MetadataShow full item record
CitationAksoy, B. A., Savci, Y. E., Mergen, A., Aydogdu, S., Dikme, G., Bozkurt, C., & Fisgin, T. (2019). Extracorporeal photopheresis treatment for steroid resistant graft versus host disease in pediatrics: Single center experience. BONE MARROW TRANSPLANTATION, 54(1), 195–196.
Background: Steroid resistant graft vs host disease (GVHD) is deﬁned as unresolved or worsened symptomatology of GVHD at day 14 despite effective immunosuppression with steroid therapy. Second line immunosuppressive agents, extracorporeal photopheresis (ECP) and/or mesenchymal stem cell therapies are being tried as salvage therapy.